Add to ORKGBackground. It is unclear if CD4 cell counts at HIV diagnosis have improved over a 10-year period of expanded HIV testing in the USA. Methods. We studied HOPS participants diagnosed with HIV infection \ue2\u2030\ua46 months prior to entry into care during 2000-2009. We assessed the correlates of CD4 count <200 cells/mm(3) at HIV diagnosis (late HIV diagnosis) by logistic regression. Results. Of 1,203 eligible patients, 936 (78%) had a CD4 count within 3 months after HIV diagnosis. Median CD4 count at HIV diagnosis was 299 cells/mm(3) and did not significantly improve over time (P = 0.13). Comparing periods 2000-2001 versus 2008-2009, respectively, 39% and 35% of patients had a late HIV diagnosis (P = 0.34). Independent correlates of late HI...
The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major determinant...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
(See the editorial commentary by Goicoechea and Smith on pages 1375–6) Background. Human immunodefic...
BACKGROUND. Initiatives to improve early detection and access to human immunodeficiency virus (HIV) ...
timely access to medical care can improve treatment outcomes [1] and potentially decrease the risk o...
The objective of this study was to investigate if patients diagnosed in community clinics have highe...
ABSTRACT Early initiation of antiretroviral therapy increases the likelihood of effective immune res...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
Abstract We assessed CD4 count at initial presentation for HIV care among ≥50-year-old...
BACKGROUND: The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
INTRODUCTION: Saint Mary\u27s Special Immunology Services (SMSIS) is a clinic that specializes in th...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
The objective of this study was to investigate if patients diagnosed in community clinics have highe...
ObjectivesTo examine changes between 2006 and 2011 in the proportion of HIV-positive patients newly-...
The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major determinant...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
(See the editorial commentary by Goicoechea and Smith on pages 1375–6) Background. Human immunodefic...
BACKGROUND. Initiatives to improve early detection and access to human immunodeficiency virus (HIV) ...
timely access to medical care can improve treatment outcomes [1] and potentially decrease the risk o...
The objective of this study was to investigate if patients diagnosed in community clinics have highe...
ABSTRACT Early initiation of antiretroviral therapy increases the likelihood of effective immune res...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
Abstract We assessed CD4 count at initial presentation for HIV care among ≥50-year-old...
BACKGROUND: The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
INTRODUCTION: Saint Mary\u27s Special Immunology Services (SMSIS) is a clinic that specializes in th...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
The objective of this study was to investigate if patients diagnosed in community clinics have highe...
ObjectivesTo examine changes between 2006 and 2011 in the proportion of HIV-positive patients newly-...
The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major determinant...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
(See the editorial commentary by Goicoechea and Smith on pages 1375–6) Background. Human immunodefic...